283 related articles for article (PubMed ID: 20345121)
1. Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry.
Naimy H; Leymarie N; Zaia J
Biochemistry; 2010 May; 49(17):3743-52. PubMed ID: 20345121
[TBL] [Abstract][Full Text] [Related]
2. Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions.
Naimy H; Buczek-Thomas JA; Nugent MA; Leymarie N; Zaia J
J Biol Chem; 2011 Jun; 286(22):19311-9. PubMed ID: 21471211
[TBL] [Abstract][Full Text] [Related]
3. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
4. Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.
Wu J; Wei J; Chopra P; Boons GJ; Lin C; Zaia J
Anal Chem; 2019 Sep; 91(18):11738-11746. PubMed ID: 31423779
[TBL] [Abstract][Full Text] [Related]
5. Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.
Naimy H; Leymarie N; Bowman MJ; Zaia J
Biochemistry; 2008 Mar; 47(10):3155-61. PubMed ID: 18260648
[TBL] [Abstract][Full Text] [Related]
6. CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides.
Schenauer MR; Yu Y; Sweeney MD; Leary JA
J Biol Chem; 2007 Aug; 282(35):25182-8. PubMed ID: 17597064
[TBL] [Abstract][Full Text] [Related]
7. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.
Huang R; Liu J; Sharp JS
Anal Chem; 2013 Jun; 85(12):5787-95. PubMed ID: 23659663
[TBL] [Abstract][Full Text] [Related]
8. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
[TBL] [Abstract][Full Text] [Related]
9. Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains.
Staples GO; Shi X; Zaia J
J Biol Chem; 2010 Jun; 285(24):18336-43. PubMed ID: 20363743
[TBL] [Abstract][Full Text] [Related]
10. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.
Chen J; Jones CL; Liu J
Chem Biol; 2007 Sep; 14(9):986-93. PubMed ID: 17884631
[TBL] [Abstract][Full Text] [Related]
11. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.
Kuberan B; Lech M; Zhang L; Wu ZL; Beeler DL; Rosenberg RD
J Am Chem Soc; 2002 Jul; 124(29):8707-18. PubMed ID: 12121115
[TBL] [Abstract][Full Text] [Related]
12. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
[TBL] [Abstract][Full Text] [Related]
13. De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.
Huang R; Zong C; Venot A; Chiu Y; Zhou D; Boons GJ; Sharp JS
Anal Chem; 2016 May; 88(10):5299-307. PubMed ID: 27087275
[TBL] [Abstract][Full Text] [Related]
14. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
[TBL] [Abstract][Full Text] [Related]
15. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
16. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
[TBL] [Abstract][Full Text] [Related]
17. The 3-
Chopra P; Joshi A; Wu J; Lu W; Yadavalli T; Wolfert MA; Shukla D; Zaia J; Boons GJ
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33441484
[TBL] [Abstract][Full Text] [Related]
18. Variability in the composition of porcine mucosal heparan sulfates.
Sargison L; Smith RAA; Carnachan SM; Daines AM; Brackovic A; Kidgell JT; Nurcombe V; Cool SM; Sims IM; Hinkley SFR
Carbohydr Polym; 2022 Apr; 282():119081. PubMed ID: 35123736
[TBL] [Abstract][Full Text] [Related]
19. Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity.
de Agostini AI; Dong JC; de Vantéry Arrighi C; Ramus MA; Dentand-Quadri I; Thalmann S; Ventura P; Ibecheole V; Monge F; Fischer AM; HajMohammadi S; Shworak NW; Zhang L; Zhang Z; Linhardt RJ
J Biol Chem; 2008 Oct; 283(42):28115-24. PubMed ID: 18669628
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 3-
Wang Z; Arnold K; Dhurandahare VM; Xu Y; Pagadala V; Labra E; Jeske W; Fareed J; Gearing M; Liu J
Anal Chem; 2022 Feb; 94(6):2950-2957. PubMed ID: 35107975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
